As of 2025-09-16, the Relative Valuation of Theravance Biopharma Inc (TBPH) is 3.91 USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.40 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -72.9%.
The range of the Relative Valuation is 2.28 - 7.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 23.3x | 10.3x |
| Forward P/E multiples | 15.3x - 30.3x | 19.9x |
| Fair Price | 2.28 - 7.84 | 3.91 |
| Upside | -84.2% - -45.6% | -72.9% |
| Date | P/E |
| 2025-09-10 | 52.71 |
| 2025-09-09 | 53.18 |
| 2025-09-08 | 53.80 |
| 2025-09-05 | 53.91 |
| 2025-09-04 | 54.30 |
| 2025-09-03 | 53.08 |
| 2025-09-02 | 53.49 |
| 2025-08-29 | 53.64 |
| 2025-08-28 | 53.99 |
| 2025-08-27 | 53.33 |
| 2025-08-26 | 53.33 |
| 2025-08-25 | 53.31 |
| 2025-08-22 | 53.76 |
| 2025-08-21 | 52.79 |
| 2025-08-20 | 51.75 |
| 2025-08-19 | 51.98 |
| 2025-08-18 | 52.60 |
| 2025-08-15 | 50.82 |
| 2025-08-14 | 50.01 |
| 2025-08-13 | 48.00 |
| 2025-08-12 | 46.07 |
| 2025-08-11 | 44.06 |
| 2025-08-08 | 44.52 |
| 2025-08-07 | 43.32 |
| 2025-08-06 | 43.21 |
| 2025-08-05 | 42.86 |
| 2025-08-04 | 43.36 |
| 2025-08-01 | 42.12 |
| 2025-07-31 | 43.13 |
| 2025-07-30 | 42.78 |
| 2025-07-29 | 42.63 |
| 2025-07-28 | 42.74 |
| 2025-07-25 | 42.63 |
| 2025-07-24 | 43.01 |
| 2025-07-23 | 43.67 |
| 2025-07-22 | 43.40 |
| 2025-07-21 | 43.86 |
| 2025-07-18 | 43.48 |
| 2025-07-17 | 44.91 |
| 2025-07-16 | 45.02 |
| 2025-07-15 | 44.56 |
| 2025-07-14 | 44.33 |
| 2025-07-11 | 43.67 |
| 2025-07-10 | 44.29 |
| 2025-07-09 | 44.79 |
| 2025-07-08 | 43.36 |
| 2025-07-07 | 43.71 |
| 2025-07-03 | 43.09 |
| 2025-07-02 | 42.70 |
| 2025-07-01 | 42.16 |